Although ApoE4 is not a modifiable risk factor for AD, this model suggests that being a carrier for it may increase ones risk of having cerebrovasculature deposits of Aβ otherwise known as cerebral amyloid angiopathy (CAA). This evidence concerns the gene APOE and cerebral amyloid angiopathy.